Global Post-Traumatic Stress Disorder Therapeutics Market
North America Dominates Global Post-Traumatic Stress Disorder Therapeutics Market in 2022, Asia-Pacific Set for Rapid Growth
July 20, 2023 09:38 ET | Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Post-Traumatic Stress Disorder Therapeutics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This...
22157.jpg
Global Depression Treatment Therapy Market Report 2022-2028: Selective Serotonin Reuptake Inhibitors (SSRIs) Hold Significant Share
October 10, 2022 06:43 ET | Research and Markets
Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Depression Treatment Therapy Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
Worldwide Depression Treatment Industry to 2026 - Increasing Awareness About Mental Illness is Accelerating Market Growth
August 05, 2021 07:58 ET | Research and Markets
Dublin, Aug. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Depression Treatment Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The rising prevalence of depression among the...
Fluoxetine Market Research Report By Size, Share, Type, Application and Top Players 2018-2026 | Reports And Data
July 24, 2019 10:01 ET | Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Fluoxetine market is a thorough analysis of the size, share, demand, growth, gross profits, earnings, and revenue of the industry. It...
Logo.PNG
Zomedica Announces Achievement of Therapeutic Development Milestones
December 12, 2017 06:55 ET | Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Logo.PNG
Zomedica Announces Two Transdermal Products for Cats
January 30, 2017 06:55 ET | Zomedica
ANN ARBOR, Mich., Jan. 30, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it opened its...